🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Heather Beckwith

University of Minnesota

ORCID: 0000-0003-3227-7525

Also affiliated with University of Minnesota Medical Center, Minnesota Oncology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer”.

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2020.2535

N/A

6.3DataRank · unranked

225 citations

Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain +74 more

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03267-1

N/A

1.4DataRank · unranked

43 citations

Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

The Lancet Oncology(2021)10.1016/s1470-2045(21)00589-1

N/A

0.917DataRank · unranked

451 citations

Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze +94 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z

N/A

0.900DataRank · unranked

27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Cancer Cell(2021)10.1016/j.ccell.2021.05.009

N/A

0.873DataRank · unranked

337 citations

Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace +40 more

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2

N/A

0.610DataRank · unranked

13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00337-2

N/A

0.510DataRank · unranked

29 citations

Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar +50 more

Emotional health concerns of oncology physicians in the United States: fallout during the COVID-19 pandemic

medRxiv(2020)10.1101/2020.06.11.20128702

N/A

0.483DataRank · unranked

24 citations

Deanna Teoh, Patricia Jewett, Heather Beckwith, Helen M. Parsons, Jianling Yuan +5 more

Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial

Frontiers in Oncology(2025)10.3389/fonc.2025.1605120

N/A

0DataRank · unranked

0 citations

Justin Lengfeld, S.P. Stoesz, Michelle Edwards, Franklin Pass, Gillian L. Hirst +6 more

Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial

Research Square(2023)10.21203/rs.3.rs-2588168/v1

N/A

0DataRank · unranked

0 citations

Douglas Yee, David A. Potter, Patricia Jewett, Christina Yau, Heather Beckwith +7 more

Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic

PLoS ONE(2020)10.1371/journal.pone.0242767

N/A

0DataRank · unranked

63 citations

Deanna Teoh, Patricia Jewett, Heather Beckwith, Helen M. Parsons, Jianling Yuan +5 more

Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial

Breast Cancer Research and Treatment(2024)10.1007/s10549-023-07214-5

N/A

0DataRank · unranked

5 citations

Douglas Yee, David A. Potter, Patricia Jewett, Christina Yau, Heather Beckwith +7 more